Bone marrow micrometastases as a prognostic factor in early breast cancer patients

Journal of B.U.ON.

Volumn 8, Issue 2, 2003, Pages 133-137

  Alexandrova, E ^a   Sergieva, S ^a   Nikolova, V ^b   Danon, S ^a  

^a National Cancer Hospital   (Bulgaria)

^b Natl Ctr of Haematol/Transfusiol   (Bulgaria)

Author keywords

Bone marrow micrometastases; Bone metastases; Early breast cancer; Prognostic criteria

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE METASTASIS; BREAST CANCER; CANCER SURGERY; CHI SQUARE TEST; CONFIDENCE INTERVAL; CYTOCHEMISTRY; CYTOLOGY; DISSEMINATED CANCER; EARLY CANCER; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; HUMAN TISSUE; ILIAC CREST; INCIDENCE; KAPLAN MEIER METHOD; LUNG METASTASIS; MAJOR CLINICAL STUDY; METHODOLOGY; PROGNOSIS; RISK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; TUMOR VOLUME;

EID: 0344444733     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Osaki T, Oyama T, Inouei M et al. Lung cancer; Prognostic implications. Jpn J Thorac Cardiovasc Surg 2001; 49: 545-551.
2. Leinung S, Wurl P, Schonfelder et al. Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. J Hematother Stem Cell Res 2000; 9: 905-911.
3. Weckerman D, Muller P, Wawroschek F et al. Micrometastases of bone marrow in localized prostate cancer; Correlation with established risk factors. J Clin Oncol 1999; 7: 3438-3443.
4. Braun S, Pantel K, Muller P et al. Cytokeratin-positive cells in bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000; 342: 525-533.
5. Ikeda N, Miyoshi Y, Motomura K et al. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA. Jpn J Cancer Res 2000; 91: 918-924.
6. Braun S, Gevetli BS, Assemi C et al. Comparative analysis of micrometastases to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001; 19: 1468-1475.
7. Ooka M, Tamaki Y, Sakita I et al. Bone marrow micrometastases detected by RT-PCR for mammoglobin can be an alternative prognostic factor of breast cancer. Breast Cancer Res Treat 2001; 67: 169-175.
8. Braun S, Pantel K. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients. Oncologist 2001; 6: 1083-1032.
9. Nahon S, Brewer Y, Kirscher S et al. Axillary lymph node and bone marrow micrometastases of breast cancer. Bull Cancer 2001; 88: 1095-1104.
10. Braun S, Schlimok G, Heumos I et al. erB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res 2001; 61: 1890-1895.
11. Gerber B, Krause A, Muller H et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factor. J Clin Oncol 2001; 19: 960-971.
12. Diel I. Bone marrow staging for breast cancer: Is it better than axillary node dissection. Semin Oncol 2001; 28: 236-244.
13. Diel I. Prognostic factors for skeletal relapse in breast cancer. Cancer Treat Rev 2001; 27: 153-157.
14. Simmons R, Hoda S, Osborn M et al. Bone marrow micrometastases in breast cancer patients. Am J Surg 2000; 180: 309-312.
15. Funke I, Schaut W. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be sustained. J Clin Oncol 1998; 16: 557-566.